# RELAY THERAPEUTICS INC (RLAY)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/RLAY/

- Reporting holders: 6
- Reported value: $14.8M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [CONGRESS ASSET MANAGEMENT CO](https://holderbook.com/funds/897378-congress-asset-management-co/) | $14.1M | 779,544 | 0.1% | 14 |
| [Valeo Financial Advisors, LLC](https://holderbook.com/funds/1722641-valeo-financial-advisors-llc/) | $636.3K | 35,251 | 0.0% | 3 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $75.0K | 4,156 | 0.0% | 9 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $51.4K | 2,850 | 0.0% | 4 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $10.1K | 559 | 0.0% | 7 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $1.5K | 81 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 6 | $14.8M |
| Q2 2026 | 265 | $4.9B |
| Q1 2026 | 243 | $1.9B |
| Q4 2025 | 227 | $1.5B |
| Q3 2025 | 200 | $876.2M |
| Q2 2025 | 207 | $597.2M |
| Q1 2025 | 208 | $441.8M |
| Q4 2024 | 199 | $680.6M |
| Q3 2024 | 196 | $1.2B |
| Q2 2024 | 178 | $864.3M |
| Q1 2024 | 187 | $1.2B |
| Q4 2023 | 177 | $1.5B |